CBOE · Insider Trading
Cboe Global Markets, Inc.
Every open-market purchase and sale reported by CBOE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-14 | Fredric J Tomczyk | Director | MIXED | — | — |
| 2026-08-21 | Heidi Fischer | EVP, Equities and Spot Markets | A | +2,900 deriv. | — |
| 2026-08-21 | Boudewijn Duinstra | EVP, CHIEF RISK OFFICER | A | +2,404 deriv. | — |
| 2026-08-14 | Janet P Froetscher | Director | Sell | −937 | −$261.38K |
| 2026-07-02 | Fredric J Tomczyk | Director | F | −337 | −$83.48K |
| 2026-05-21 | Allen Wilkinson | SVP, CHIEF ACCOUNTING OFFICER | A | +166 deriv. | — |
| 2026-05-20 | Janet P Froetscher | Director | Sell | −1,223 | −$437.94K |
| 2026-05-18 | James E. Parisi | Director | A | +530 | — |
| 2026-05-18 | Jennifer J McPeek | Director | A | +530 | — |
| 2026-05-18 | Erin Mansfield | Director | A | +530 | — |
| 2026-05-18 | Cecilia Mao | Director | A | +530 | — |
| 2026-05-18 | Jill R Goodman | Director | A | +530 | — |
| 2026-05-18 | Janet P Froetscher | Director | A | +530 | — |
| 2026-05-18 | Ivan K Fong | Director | A | +530 | — |
| 2026-05-18 | Edward J. Fitzpatrick | Director | A | +530 | — |
| 2026-05-18 | William M Farrow III | Director | A | +530 | — |
| 2026-05-18 | Roderick A Palmore | Director | A | +530 | — |
| 2026-05-18 | Fredric J Tomczyk | Director | A | +530 | — |
| 2026-02-25 | Allen Wilkinson | SVP, CHIEF ACCOUNTING OFFICER | Sell | −248 | −$72.61K |
| 2026-02-23 | John P Sexton | EVP, GC AND CORP SEC | MIXED | +1,581 | +$452.43K |
| 2026-02-23 | Allen Wilkinson | SVP, CHIEF ACCOUNTING OFFICER | MIXED | +410 | +$117.33K |
| 2026-02-23 | Jill Griebenow | EVP, CFO | MIXED | +2,560 | +$732.60K |
| 2026-02-23 | Stephanie Foley | EVP, CHRO | MIXED | +1,051 | +$300.76K |
| 2026-02-23 | Craig S Donohue | CEO | MIXED | +2,604 | +$745.19K |
| 2026-02-23 | Robert A Hocking | EVP, Global Head of Derivs. | MIXED | +232 | +$66.39K |
| 2026-02-23 | Prashant Bhatia | EVP, Strategy & Corp Dev | MIXED | +95 | +$27.19K |
| 2026-02-23 | Timothy Lipscomb | EVP, Chief Technology Officer | MIXED | +1,022 | +$292.47K |
| 2026-02-23 | Fredric J Tomczyk | Director | MIXED | +4,538 | +$1.30M |
| 2026-02-23 | Christopher A Isaacson | EVP, COO | MIXED | +3,315 | +$948.65K |
| 2026-02-20 | Edward J. Fitzpatrick | Director | Sell | −3,947 | −$1.13M |
| 2026-02-20 | Alexander Matturri JR | Director | Sell | −1,500 | −$428.04K |
| 2026-02-17 | Stephanie Foley | EVP, CHRO | MIXED | +150 | −$30.85K |
| 2026-02-17 | John P Sexton | EVP, GC AND CORP SEC | MIXED | +5,944 | −$1.02M |
| 2026-02-17 | Christopher A Isaacson | EVP, COO | MIXED | +9,164 | −$1.72M |
| 2026-02-17 | Jill Griebenow | EVP, CFO | MIXED | +3,723 | −$814.78K |
| 2025-10-22 | Robert A Hocking | EVP, Global Head of Derivs. | A | +1,066 deriv. | — |
| 2025-10-15 | Fredric J Tomczyk | Director | MIXED | +8,253 | +$2.02M |
| 2025-09-04 | Christopher A Isaacson | EVP, COO | Sell | −5,000 | −$1.18M |
| 2025-09-04 | Prashant Bhatia | EVP, Ent Strat & Corp Dev | A | +674 deriv. | — |
| 2025-08-21 | Stephanie Foley | EVP, CHRO | MIXED | +1,189 | +$292.65K |
| 2025-07-17 | Timothy Lipscomb | EVP, Chief Technology Officer | A | +376 deriv. | — |
| 2025-07-17 | Christopher A Isaacson | EVP, COO | A | +940 deriv. | — |
| 2025-07-17 | John P Sexton | EVP, GC AND CORP SEC | A | +251 deriv. | — |
| 2025-07-17 | Catherine R Clay | EVP, GLOBAL DERIVATIVES | A | +627 deriv. | — |
| 2025-07-03 | Fredric J Tomczyk | Director | A | +623 | — |
| 2025-06-11 | Christopher A Isaacson | EVP, COO | Sell | −5,000 | −$1.11M |
| 2025-05-28 | Catherine R Clay | EVP, GLOBAL DERIVATIVES | Sell | −3,598 | −$815.23K |
| 2025-05-21 | Timothy Lipscomb | EVP, Chief Technology Officer | MIXED | +701 | +$157.31K |
| 2025-05-09 | Craig S Donohue | CEO | A | +26,856 deriv. | — |
| 2025-05-08 | James E. Parisi | Director | A | +729 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Fredric J Tomczyk | Director | 50,449 | $16.93M |
| Christopher A Isaacson | EVP, COO | 50,198 | $16.84M |
| John P Sexton | EVP, GC AND CORP SEC | 29,965 | $10.05M |
| Roderick A Palmore | Director | 27,730 | $9.30M |
| Jill Griebenow | EVP, CFO | 14,953 | $5.02M |
| Edward J. Fitzpatrick | Director | 13,451 | $4.51M |
| Dave Howson | EVP, GLOBAL PRESIDENT | 13,309 | $4.47M |
| Janet P Froetscher | Director | 12,870 | $4.32M |
| William M Farrow III | Director | 12,735 | $4.27M |
| Jill R Goodman | Director | 12,448 | $4.18M |
| James E. Parisi | Director | 9,969 | $3.34M |
| Ivan K Fong | Director | 7,441 | $2.50M |
| Jennifer J McPeek | Director | 6,368 | $2.14M |
| Alexander Matturri JR | Director | 4,761 | $1.60M |
| Stephanie Foley | EVP, CHRO | 3,842 | $1.29M |
| Craig S Donohue | CEO | 2,604 | $873.72K |
| Cecilia Mao | Director | 2,441 | $819.03K |
| Erin Mansfield | Director | 2,441 | $819.03K |
| Adam Inzirillo | EVP, DATA VANTAGE | 2,414 | $809.97K |
| Catherine R Clay | EVP, GLOBAL DERIVATIVES | 2,183 | $732.46K |
| Timothy Lipscomb | EVP, Chief Technology Officer | 1,950 | $654.28K |
| Robert A Hocking | EVP, Global Head of Derivs. | 514 | $172.46K |
| Allen Wilkinson | SVP, CHIEF ACCOUNTING OFFICER | 410 | $137.57K |
| Prashant Bhatia | EVP, Strategy & Corp Dev | 95 | $31.88K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CBOE quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.